Physician
Gastroenterology
Dr. Karen L. Lindsay, MD
|
|
Give Review
Dr. Karen L. Lindsay practices Gastroenterology. She went to University of Wisconsin School of Medicine and Public Health. She received awards:"Super Doctor". Doctor Karen L. Lindsay, MD is also a published doctor. She has 85 publication published. The most recent publication is: Hepatitis C.
Publications
- The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
- Hepatitis C virus: a critical appraisal of approaches to therapy.
- Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
- Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis.
- More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis.
- Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
- Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
- Treatment of chronic hepatitis C infection: one step at a time.
- Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.
- Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.
- Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
- Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.
- Introduction to therapy of hepatitis C.
- Use of complementary and alternative medicine in patients with liver disease.
- Validation of the defining characteristics of potential for violence.
- Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia.
- The composite DAS Score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making.
- Adenocarcinoma in a choledochal cyst during pregnancy: a case report and guidelines for management.
- Suspected ectopic pregnancy. Can it be predicted by history and examination?
- Hepatitis C.
- The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach.
- Hepatitis B vaccine: low postvaccination immunity in hospital personnel given gluteal injections.
- Diagnostic usefulness of testing for anti-HBc IgM in acute hepatitis B.
- Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
- Spontaneous Arizona hinshawii peritonitis in cirrhosis with ascites.
- Management of chronic hepatitis in special populations.
- Comparison of serum and urine hCG levels with SP1 and PAPP-A levels in patients with first-trimester vaginal bleeding.
- Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
- Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection.
- Therapy of hepatitis C: overview.
- Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.
- Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.
- Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers.
- Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
- Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States....
- Delayed HBsAg clearance in chronic hepatitis B viral infection.
- Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.
- Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
- Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.
- Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional T...
- Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group.
- Complementary and alternative medicine in chronic liver disease.
- Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.
- Treatment of chronic hepatitis C: comparative virologic response rates among the different interferons.
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
- Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical a...
- A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Thera...
- Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.
- Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County.
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
- Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
- Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.
- Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.
- Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis.
- Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
- Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
- Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
- Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial.
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
- Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.
- Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
- Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
- Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
- Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepati...
- Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
- Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
- Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
- Inadequate numbers.
- Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C.
- Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
- Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
- HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
- Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C.
- Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
- Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
- Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
- Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
- Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepa...
- Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
- Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.
- Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
- No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C.
Schools
University of Wisconsin Madison
Lac Usc Med Center
Los Angeles County University Of California Med Center
UCLA Med Center
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Super Doctor
Education
-
VA Greater Los Angeles Healthcare System -
University of Southern California - LAC+USC Medical Center -
University of Wisconsin School of Medicine and Public Health
Helpful Reviews
Similar Doctors
|
Dr. Claudia P. Sanmiguel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin A. Ghassemi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gil Y. Melmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lily Dara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahid H. Sial, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mazen Noureddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Hollander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia J. Morton, MD |
|
|
Dr. Donna E. Goldman, MD |
|
|
Dr. David D. Kim, MD |
|
|
Dr. Kareem H. Sassi, MD |
|
|
Sharon E. Kim |